Clinical Trials Browser

Phase 1 × Suspended × Breast Neoplasms × Clear all

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04120246 2024-07-10

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Phase 1 Suspended

24 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

Phase 1 Suspended

30 enrolled

BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Phase 1 Suspended

220 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT00673829 2016-06-17

Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

Phase 1 Suspended

26 enrolled

Breast

Breast Neoplasms

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Phase 1 Suspended

24 enrolled

BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Clinical Trials

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

DNX-2440 for Resectable Colorectal Liver Metastasis

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer